ADAXIQ Trademark

Trademark Overview

On Wednesday, October 31, 2018, a trademark application was filed for ADAXIQ with the United States Patent and Trademark Office. The USPTO has given the ADAXIQ trademark a serial number of 88175892. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 11, 2022. This trademark is owned by Revance Therapeutics, Inc. The ADAXIQ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, wrinkles, hyperhydrosis, sports injuries, namely, injured or torn skin, muscle, ligaments, or bone, cerebral palsy, muscle spasms, muscle tremors and pain; pharmaceutical preparations, namely, peptide substrates for use in the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, sports injuries, namely, injured or torn skin, muscle, ligaments, or bone, cerebral palsy, muscle spasms, muscle tremors and pain; body creams, lotions and gels for medical purposes; eye creams, lotions and gels for medical purposes
adaxiq

General Information

Serial Number88175892
Word MarkADAXIQ
Filing DateWednesday, October 31, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 11, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 9, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, wrinkles, hyperhydrosis, sports injuries, namely, injured or torn skin, muscle, ligaments, or bone, cerebral palsy, muscle spasms, muscle tremors and pain; pharmaceutical preparations, namely, peptide substrates for use in the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, sports injuries, namely, injured or torn skin, muscle, ligaments, or bone, cerebral palsy, muscle spasms, muscle tremors and pain; body creams, lotions and gels for medical purposes; eye creams, lotions and gels for medical purposes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, November 15, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameRevance Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNewark, CA 94560
Party NameRevance Therapeutics, Inc
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNewark, CA 94560

Trademark Events

Event DateEvent Description
Monday, July 11, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 11, 2022ABANDONMENT - NO USE STATEMENT FILED
Tuesday, October 26, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 25, 2021SOU EXTENSION 5 GRANTED
Thursday, October 21, 2021SOU EXTENSION 5 FILED
Thursday, October 21, 2021SOU TEAS EXTENSION RECEIVED
Thursday, May 13, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 12, 2021SOU EXTENSION 4 GRANTED
Friday, May 7, 2021SOU EXTENSION 4 FILED
Friday, May 7, 2021SOU TEAS EXTENSION RECEIVED
Thursday, November 26, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 25, 2020SOU EXTENSION 3 GRANTED
Monday, November 9, 2020SOU EXTENSION 3 FILED
Monday, November 23, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, November 9, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, May 19, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 15, 2020SOU EXTENSION 2 GRANTED
Friday, May 15, 2020SOU EXTENSION 2 FILED
Friday, May 15, 2020SOU TEAS EXTENSION RECEIVED
Wednesday, November 27, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 25, 2019SOU EXTENSION 1 GRANTED
Monday, November 25, 2019SOU EXTENSION 1 FILED
Monday, November 25, 2019SOU TEAS EXTENSION RECEIVED
Tuesday, June 4, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 9, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 9, 2019PUBLISHED FOR OPPOSITION
Wednesday, March 20, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, February 25, 2019ASSIGNED TO LIE
Thursday, February 7, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, February 7, 2019EXAMINER'S AMENDMENT ENTERED
Thursday, February 7, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, February 7, 2019EXAMINERS AMENDMENT E-MAILED
Thursday, February 7, 2019EXAMINERS AMENDMENT -WRITTEN
Tuesday, February 5, 2019ASSIGNED TO EXAMINER
Thursday, November 15, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, November 3, 2018NEW APPLICATION ENTERED

Related Keywords

adaxiq muscle disorders namely cerebral palsy bone skin ligaments spasms pain